Everyday Health
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Stage
Acquired - IITotal Raised
$75MInvestors Count
12Deal Terms
6Portfolio Exits
2Everyday Health Funding, Everyday Health Valuation & Everyday Health Revenue
9 Fundings
Everyday Health's latest funding round was a Acq - P2P for on December 5, 2016.
Everyday Health's valuation in March 2014 was $415.49M.
Everyday Health's latest post-money valuation is from December 2016.
Sign up for a free trial to see Everyday Health's valuations in December 2016, November 2010 and more.
Everyday Health's 2008 revenue was $69M. Everyday Health's most recent revenue is from 2008.
Sign up for a free trial to see revenue data from 2013 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
12/5/2016 | Acq - P2P | 3 | ||||
3/28/2014 | IPO | ▲$415.49M | ||||
11/11/2010 | Series G | |||||
10/15/2010 | Series F | |||||
11/24/2008 | Series E | $69M (3.58x) FY 2008 |
Date | 12/5/2016 | 3/28/2014 | 11/11/2010 | 10/15/2010 | 11/24/2008 |
|---|---|---|---|---|---|
Round | Acq - P2P | IPO | Series G | Series F | Series E |
Amount | |||||
Investors | |||||
Valuation | ▲$415.49M | ||||
Revenue | $69M (3.58x) FY 2008 | ||||
Sources | 3 |
Financials
Income Statement
Income Statement | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|
Total Sales (or Revenue) | |||
Cost of Goods Sold (COGS) including Depreciation and Ammortization | |||
Gross Income | |||
SG&A Excluding Other | |||
Other Operating Expense | |||
EBIT (Operating Income) | |||
Non-Operating Income (Expense) | |||
Interest Expense | |||
Usual Expense | |||
Pretax Income | |||
Income Taxes | |||
Equity in Earnings of Affiliates Income | |||
Other After Tax Adjustments | |||
Consolidated Net Income | |||
Minority Interest Expense | |||
Net Income From Continuing Operations | |||
Preferred Dividends | |||
Net Income Available to Common | |||
EPS (Recurring) | |||
EPS - Basic - Before Extraordinaries | |||
EPS (Diluted) | |||
EBITDA | |||
Stock Option Compensation Expense | |||
Operating Lease Expense | |||
Foreign Currency Adjustment (Net) |
Income Statement | Total Sales (or Revenue) | Cost of Goods Sold (COGS) including Depreciation and Ammortization | Gross Income | SG&A Excluding Other | Other Operating Expense | EBIT (Operating Income) | Non-Operating Income (Expense) | Interest Expense | Usual Expense | Pretax Income | Income Taxes | Equity in Earnings of Affiliates Income | Other After Tax Adjustments | Consolidated Net Income | Minority Interest Expense | Net Income From Continuing Operations | Preferred Dividends | Net Income Available to Common | EPS (Recurring) | EPS - Basic - Before Extraordinaries | EPS (Diluted) | EBITDA | Stock Option Compensation Expense | Operating Lease Expense | Foreign Currency Adjustment (Net) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/2021 | |||||||||||||||||||||||||
12/31/2020 | |||||||||||||||||||||||||
12/31/2019 |
All numbers in millions (except EPS)Market Data by Xignite
Financials
Balance Sheet
Balance Sheet | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|
Cash & Short Term Investments | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Net Property, Plant & Equipment | |||
Total Investments and Advances | |||
Long-Term Note Receivable | |||
Intangible Assets | |||
Deferred Tax Assets | |||
Other Assets | |||
Total Assets | |||
Short Term Debt (including Current Portion of Long Term Debt) | |||
Accounts Payable | |||
Income Tax Payable | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Long Term Debt | |||
Provision for Risks Charges | |||
Deferred Tax Liabilities | |||
Other Liabilities | |||
Total Liabilities | |||
Non-Equity Reserves | |||
Preferred Stock - Carrying Value | |||
Common Equity | |||
Total Shareholders Equity | |||
Accumulated Minority Interest | |||
Total Equity | |||
Total Liabilites & Stockholders Equity | |||
Book Value Per Share | |||
Tangible Book Value Per Share |
Balance Sheet | Cash & Short Term Investments | Inventories | Other Current Assets | Total Current Assets | Net Property, Plant & Equipment | Total Investments and Advances | Long-Term Note Receivable | Intangible Assets | Deferred Tax Assets | Other Assets | Total Assets | Short Term Debt (including Current Portion of Long Term Debt) | Accounts Payable | Income Tax Payable | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Provision for Risks Charges | Deferred Tax Liabilities | Other Liabilities | Total Liabilities | Non-Equity Reserves | Preferred Stock - Carrying Value | Common Equity | Total Shareholders Equity | Accumulated Minority Interest | Total Equity | Total Liabilites & Stockholders Equity | Book Value Per Share | Tangible Book Value Per Share |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/2021 | ||||||||||||||||||||||||||||||
12/31/2020 | ||||||||||||||||||||||||||||||
12/31/2019 |
All numbers in millions (except EPS)Market Data by Xignite
Financials
Cash Flow
Cash Flow | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|
Net Income (Starting Line) | |||
Depreciation | |||
Deferred Taxes & Investment Tax Credit | |||
Other Funds (Non Cash) | |||
Funds from Operations | |||
Extraordinary Item | |||
Changes in Working Capital | |||
Net Operating Cash Flow | |||
Capital Expenditures | |||
Net Assets From Acquisitions | |||
Sale of Fixed Assets and Businesses | |||
Purchase or Sale of Investments | |||
Other Uses | |||
Other Sources | |||
Net Investing Cash Flow | |||
Cash Dividends Paid | |||
Change in Capital Stock | |||
Issuance or Reduction of Debt, Net | |||
Net Financing Active Other Cash Flow | |||
Net Financing Cash Flow | |||
Exchange Rate Effect | |||
Miscellaneous Funds | |||
Net Change in Cash | |||
Free Cash Flow |
Cash Flow | Net Income (Starting Line) | Depreciation | Deferred Taxes & Investment Tax Credit | Other Funds (Non Cash) | Funds from Operations | Extraordinary Item | Changes in Working Capital | Net Operating Cash Flow | Capital Expenditures | Net Assets From Acquisitions | Sale of Fixed Assets and Businesses | Purchase or Sale of Investments | Other Uses | Other Sources | Net Investing Cash Flow | Cash Dividends Paid | Change in Capital Stock | Issuance or Reduction of Debt, Net | Net Financing Active Other Cash Flow | Net Financing Cash Flow | Exchange Rate Effect | Miscellaneous Funds | Net Change in Cash | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/2021 | ||||||||||||||||||||||||
12/31/2020 | ||||||||||||||||||||||||
12/31/2019 |
All numbers in millions (except EPS)Market Data by Xignite
Everyday Health Deal Terms
6 Deal Terms
Everyday Health's deal structure is available for 6 funding rounds, including their Acq - P2P from December 05, 2016.
Round | Acq - P2P | IPO | Series G | Series D | Series C |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acq - P2P | |||||||||||||||
IPO | |||||||||||||||
Series G | |||||||||||||||
Series D | |||||||||||||||
Series C |
Everyday Health Investors
12 Investors
Everyday Health has 12 investors. Ziff Davis invested in Everyday Health's Acq - P2P funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
12/5/2016 | 12/5/2016 | 1 Acq - P2P | Corporation | New York | ||
3/22/2004 | 11/11/2010 | 5 Series C, Series D (2007), Series E (2008), Series B (2004), Series G (2010) | Venture Capital | New York | ||
9/12/2007 | 11/11/2010 | 3 Series D, Series E (2008), Series G (2010) | Venture Capital | California | ||
Growth Equity | California | |||||
Venture Capital | Connecticut |
First funding | 12/5/2016 | 3/22/2004 | 9/12/2007 | ||
|---|---|---|---|---|---|
Last Funding | 12/5/2016 | 11/11/2010 | 11/11/2010 | ||
Investor | |||||
Rounds | 1 Acq - P2P | 5 Series C, Series D (2007), Series E (2008), Series B (2004), Series G (2010) | 3 Series D, Series E (2008), Series G (2010) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Growth Equity | Venture Capital |
Location | New York | New York | California | California | Connecticut |
Everyday Health Acquisitions
8 Acquisitions
Everyday Health acquired 8 companies. Their latest acquisition was Lifecycle Marketing on January 31, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/31/2022 | Acquired | 3 | ||||
8/27/2019 | Series B | |||||
12/4/2017 | ||||||
8/11/2015 | ||||||
3/23/2015 |
Date | 1/31/2022 | 8/27/2019 | 12/4/2017 | 8/11/2015 | 3/23/2015 |
|---|---|---|---|---|---|
Investment Stage | Series B | ||||
Companies | |||||
Valuation | |||||
Total Funding | |||||
Note | Acquired | ||||
Sources | 3 |
Everyday Health Portfolio Exits
2 Portfolio Exits
Everyday Health has 2 portfolio exits. Their latest portfolio exit was Tea Leaves Health on October 11, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/11/2017 | Acquired - II | 2 | |||
Date | 10/11/2017 | |
|---|---|---|
Exit | Acquired - II | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 2 |
You May Also Like
Dr. Joe is an engagement and education network focused on making health and wellness information understandable, refreshingly simple and smart.
Healthily design and deliver online health programs that leverage GoShare’s scheduling functionality, and webinar technology.
WebMD provides health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The company engages consumers, physicians and other healthcare professionals across a multiscreen experience, allowing us to empower and enable health decisions anytime and anywhere.
Healthline Media provides health and wellness information to consumers through its website, Healthline.com. The company's mission is to be its users' trusted ally in their pursuit of health and well-being.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.